Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notification of Major Interest in Shares

7th Jan 2016 13:56

RNS Number : 1796L
Alliance Pharma PLC
07 January 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Alliance Pharma Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

FMR LLC

4. Full name of shareholder(s)  (if different from 3.):

See Section 9

5. Date of the transaction and date onwhich the threshold is crossed orreached:

5th January 2016

6. Date on which issuer notified:

6th January 2016

7. Threshold(s) that is/are crossed orreached:

6%

 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Indirect

Direct

Indirect

Direct

Indirect

 

GB0031030819

27,557,843

27,557,843

28,657,843

28,657,843

6.12%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

28,657,843

6.12

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Controlled Undertaking

Percentage Holding

FMR (JP) LTD-FIDELITY MANAGEMENT & RESEARCH (JAPAN) LIMITED

0.80

FMRC-FMR CO., INC

5.19

PGALLC-PYRAMIS GLOBAL ADVISORS, LLC

0.02

PYRAMIS GLOBAL-PYRAMIS GLOBAL ADVISORS TRUST COMPANY

0.11

Grand Total

6.12

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will acquire:

12. Date on which proxy holder will acquire voting rights:

13. Additional information:

A threshold crossing by a controlled undertaking.

14. Contact name:

Sally- Ann Hatton

15. Contact telephone number:

 

[email protected], 01737 837148

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEADFXESDKEFF

Related Shares:

Alliance Pharma
FTSE 100 Latest
Value8,809.74
Change53.53